Polyisoprenyl phosphate (PIPP) signaling regulates phospholipase D activity: a ‘stop’ signaling switch for aspirin‐triggered lipoxin A4
暂无分享,去创建一个
B. Levy | C. Serhan | N. Petasis | M. Wakelam | V. Fokin | Joanna M. Clark
[1] C. Clish,et al. Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues. , 1998, The Journal of clinical investigation.
[2] C. Clish,et al. Aspirin-triggered 15-epi-lipoxin A4 (ATL) generation by human leukocytes and murine peritonitis exudates: development of a specific 15-epi-LXA4 ELISA. , 1998, The Journal of pharmacology and experimental therapeutics.
[3] R. Verger,et al. Improved purification and biochemical characterization of phospholipase D from cabbage. , 1993, Biochimica et biophysica acta.
[4] I. Shechter,et al. A deficiency of mixed function oxidase activities in the cholesterol biosynthetic pathway of human granulocytes. , 1980, Journal of lipid research.
[5] C. Serhan. Lipoxin biosynthesis and its impact in inflammatory and vascular events. , 1994, Biochimica et biophysica acta.
[6] J. Exton. New Developments in Phospholipase D* , 1997, The Journal of Biological Chemistry.
[7] G. Weissmann,et al. Release of inflammatory mediators from stimulated neutrophils. , 1980, The New England journal of medicine.
[8] J. Salmon,et al. Biosynthesis and biological activity of leukotriene B5. , 1984, Prostaglandins.
[9] L. Mcphail,et al. Phosphatidic acid as a second messenger in human polymorphonuclear leukocytes. Effects on activation of NADPH oxidase. , 1991, The Journal of clinical investigation.
[10] C. Serhan. Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity? , 1997, Prostaglandins.
[11] A. Martín,et al. Role and regulation of phospholipase D activity in normal and cancer cells. , 1997, Advances in enzyme regulation.
[12] H. Sarau,et al. Association between leukotriene B4-induced phospholipase D activation and degranulation of human neutrophils. , 1993, Biochemical pharmacology.
[13] W. Boyar,et al. Characterization of human PLD2 and the analysis of PLD isoform splice variants , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[14] H. Vainio,et al. Aspirin for the second hundred years: new uses for an old drug. , 1997, Pharmacology & toxicology.
[15] J. Lambeth,et al. Biochemistry and cell biology of phospholipase D in human neutrophils. , 1996, Chemistry and physics of lipids.
[16] R. Egan,et al. Phosphatidylcholine hydrolysis by phospholipase D determines phosphatidate and diglyceride levels in chemotactic peptide-stimulated human neutrophils. Involvement of phosphatidate phosphohydrolase in signal transduction. , 1989, The Journal of biological chemistry.
[17] B. Levy,et al. Polyisoprenyl phosphates in intracellular signalling , 1997, Nature.
[18] S. Cockcroft,et al. ADP-ribosylation Factor and Rho Proteins Mediate fMLP-dependent Activation of Phospholipase D in Human Neutrophils* , 1998, The Journal of Biological Chemistry.
[19] H. Herschman. Recent progress in the cellular and molecular biology of prostaglandin synthesis. , 1998, Trends in cardiovascular medicine.
[20] K. Seibert,et al. Discovery of a better aspirin. , 1995, Advances in prostaglandin, thromboxane, and leukotriene research.
[21] J. Haeggström,et al. Lipid mediator networks in cell signaling: update and impact of cytokines 1 , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[22] C. Serhan,et al. Induction of functional lipoxin A4 receptors in HL-60 cells. , 1993, Blood.
[23] A. Marcus. Aspirin as prophylaxis against colorectal cancer. , 1995, The New England journal of medicine.
[24] I. Akritopoulou‐Zanze,et al. Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils. , 1995, Biochemistry.
[25] A. Sabirsh,et al. The leukotriene B4 receptor functions as a novel type of coreceptor mediating entry of primary HIV-1 isolates into CD4-positive cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[26] Takao Shimizu,et al. A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis , 1997, Nature.
[27] C. Serhan,et al. Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[28] A. Martín,et al. Role and regulation of phospholipase D signalling. , 1997, Biochemical Society transactions.
[29] J. Lord,et al. Diacylglycerol and Phosphatidate Generated by Phospholipases C and D, Respectively, Have Distinct Fatty Acid Compositions and Functions , 1997, The Journal of Biological Chemistry.
[30] P. Zurer. BIOSYNTHESIS OF SQUALENE: Cationic intermediate identified in path that leads to key cholesterol precursor , 1997 .
[31] B. Blagg,et al. Biosynthesis of Squalene. Evidence for a Tertiary Cyclopropylcarbinyl Cationic Intermediate in the Rearrangement of Presqualene Diphosphate to Squalene , 1996 .
[32] S. Weiss. Tissue destruction by neutrophils. , 1989, The New England journal of medicine.
[33] T. Takano,et al. Aspirin-triggered 15-Epi-Lipoxin A4 (LXA4) and LXA4 Stable Analogues Are Potent Inhibitors of Acute Inflammation: Evidence for Anti-inflammatory Receptors , 1997, The Journal of experimental medicine.
[34] Robert,et al. Phosphatidylcholine Hydrolysis by Phospholipase D Determines Phosphatidatle and Diglyceride Levels in Chemotactic Peptide-stimulated Human Neutrophils , 2001 .
[35] P. Naccache,et al. Biosynthesis and biological activity of leukotriene B4. , 1990, Clinical biochemistry.
[36] J. Gomez-Cambronero. Immunoprecipitation of a phospholipase D activity with antiphosphotyrosine antibodies. , 1995, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.